IUD users in Norway are at low risk for genital C. trachomatis infection

From May 1993 to April 1995, 30 general practitioners located at 13 general practice settings in the city of Trondheim, central Norway, recruited 957 eligible participants in a prospective use-effectiveness study on performance of two copper IUDs. In this report we focus on screening for C. trachoma...

Full description

Saved in:
Bibliographic Details
Published in:Contraception (Stoneham) 1996-10, Vol.54 (4), p.209-212
Main Authors: Skjeldestad, F.E., Halvorsen, L.E., Kahn, H., Nordbø, S.A., Saake, K.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Biological and medical sciences
Birth control
C. trachomatis
Chlamydia Infections - diagnosis
Chlamydia Infections - epidemiology
Chlamydia trachomatis - genetics
Chlamydia trachomatis - pathogenicity
Female
Follow-Up Studies
Gynecology. Andrology. Obstetrics
Humans
insertion
intrauterine devices
Intrauterine Devices, Copper
Medical sciences
Middle Aged
Norway - epidemiology
Other methods of contraception. Sterilization
Patient Dropouts
Population
Prevalence
Prospective Studies
Risk Factors
screening
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:From May 1993 to April 1995, 30 general practitioners located at 13 general practice settings in the city of Trondheim, central Norway, recruited 957 eligible participants in a prospective use-effectiveness study on performance of two copper IUDs. In this report we focus on screening for C. trachomatis at insertion and its possible effect on cause-related terminations during the first 90 days after insertion. All women were screened at IUD insertion for C. trachomatis. All specimens were analyzed applying a nucleic acid test (rRNA, GenProbe). Five out of 957 women (0.5%) were positive for C. trachomatis. All were treated within two weeks of diagnosis. No cases of pelvic inflammatory disease were diagnosed during the first three months of the study. Screening for C. trachomatis at IUD insertion is not recommended in Norwegian women because of the extremely low prevalence of C. trachomatis in those who choose IUD as their primary contraceptive method. Recommendations for universally screening women for sexually transmitted diseases at IUD insertion should be based upon review of local/national prevalence data.
ISSN:0010-7824
1879-0518
DOI:10.1016/S0010-7824(96)00190-4